secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2022-03-18T23:59:59+00:00
Accession:  0001558370-22-003920
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRx Pharmaceuticals appoints Ira Strassberg as CFO and Treasurer effective March 15, 2022
--------------------------------------------------------------------------------

- Ira Strassberg appointed CFO and Treasurer effective March 15, 2022; had been financial consultant since August 2021.
- Compensation: $400k base salary, $200k target bonus, and options for 425k shares at $3.10/share vesting over two years.
- Previous roles include Deputy CFO of Cantor Fitzgerald, CFO of Cantor Commercial Real Estate, and senior roles at KPMG.
- Severance: one-year base salary plus prorated bonus if terminated without cause or for good reason; accelerated vesting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000155837022003920/0001558370-22-003920-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000155837022003920/nrxp-20220315x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-003920

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer